Kennedy Giulia C's Form 4/A amendment
AmendedVeracyte, Inc. (VCYT) · filed Mar 9, 2022
- Accession no.
- 0001384101-22-000054
- Filed
- Mar 9, 2022
- Trade date
- Mar 3-4, 2022
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Mar 7, 2022
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $578.5K. It was filed 6 days after the trade.
This amendment replaces 0001384101-22-000046 (filed Mar 7, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy Giulia CCIK 0001769333 | Officer (Chief Scientific & Med Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Common Stock | AGrant or awardAcquired | +42,412 | $0.00 | $0 | 79,987 | Direct | |
| Mar 4, 2022 | Common Stock | MOption exerciseAcquired | +4,407 | $5.98 | +$26,353.86 | 84,394 | Direct | |
| Mar 4, 2022 | Common Stock | SSaleDisposed | −17,089 | $24.91F3 | −$425,686.99 | 67,305 | Direct | |
| Mar 4, 2022 | Common Stock | SSaleDisposed | −5,844 | $25.70F4 | −$150,190.8 | 61,461 | Direct | |
| Mar 4, 2022 | Common Stock | SSaleDisposed | −100 | $26.49 | −$2,649 | 61,361 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Common Stock | AGrant or awardAcquired | +77,287 | $0.00 | $0 | 77,287 | Direct | |
| Mar 4, 2022 | Common Stock | MOption exerciseDisposed | −4,407 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
- F2
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $24.40 to $25.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents weighted average sales price. Sale prices for the transactions range from $25.41 to $26.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- F6
The option is fully vested.
Remarks
This amendment to Form 4 filed on March 7, 2022 is filed to correct the amount of securities sold on March 4, 2022 and the sale price applicable thereto as reflected in Column 4 of Table 1.